Head-to-head · Value Score
Invigor Medical vs Breeze Meds
Two GLP-1 deals, scored on the same six factors. Invigor Medical lands a Value Score of 82, Breeze Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
Invigor Medical
#49 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameBreeze Meds
#95 · Grade B- · Fair Price
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
Invigor Medical takes it on Value Score, 82 to 78 — an est. $199/mo first month, with no teaser step-up baked in. Breeze Meds isn't out of it: Shoppers who want a no-risk start and will ask what their actual dose costs before committing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Invigor Medical | Breeze Meds |
|---|---|---|
| Value Score | 82 (B+) | 78 (B-) |
| Est. first month | $199/mo | $199/mo |
| Save vs brand-name | ~85% | ~85% |
| Semaglutide | $199/mo | From $199/mo |
| Tirzepatide | $339/mo | From $299/mo first month, $399/mo thereafter |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | Not disclosed | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Invigor Medical
Mid-market flat pricing on both molecules from a long-running, broad-catalog operator.
Why it's a deal
- Both molecules priced up front
- Long-running operator with a broad catalog
- No known teaser-rate tier
The fine print
- Tirzepatide ($339) runs pricier than the best deals
- Does not publish an explicit states-served list
Breeze Meds
Nationwide and charges nothing until you are approved, but its quoted prices are floors rather than what a working dose costs.
Why it's a deal
- Nothing charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, all 50 states, cancel or change plan at any time
The fine print
- Every figure quoted is for the LOWEST dose — the funnel says higher doses may cost more
- The $299 tirzepatide is a first-month rate; month-to-month is $399
- No molecule is named behind the public "from $199" — pricing only appears inside the intake
- An $80 consultation fee applies if you are approved and then decline
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Invigor Medical is ranked on the Invigor Medical alternatives ranking, and the same list for the other side is on alternatives to Breeze Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.